On November 3, 2025, Tharimmune, Inc. announced two securities offerings, raising funds through shares sold at $3.075 each and pre-funded warrants, involving accredited investors. The proceeds will support ongoing operations and a cryptocurrency treasury strategy, with significant contingent on shareholder approval.